ProQR Prices IPO At $102M Despite Other Biotech Flops
Dutch biopharmaceutical company ProQR Therapeutics BV is going through with plans to raise up to $102 million in an initial public offering despite two biotech IPOs flopping earlier this month....To view the full article, register now.
Already a subscriber? Click here to view full article